ZHU Chunran1, ZHANG Hongbo2, LIAN Zehao3, LI Yuntao4, CHEN Xingyuan5, HUANG Boyuan6, CHEN Lin6, TANG Zhouping7
Objective: Addressing the limitations of existing treatments for hemifacial spasm and post-facial paralysis sequelae, to establish a standardized technical system for percutaneous stylomastoid foramen facial nerve radiofrequency modulation that integrates multimodal imaging guidance with electrophysiological verification, and to elucidate its indications, operational procedures, and safety. Methods: The “triple guidance” technique was adopted: (1) Preoperative thin-section CT three-dimensional reconstruction of the stylomastoid foramen and planning of the puncture path; (2) Intraoperative ultrasound (with color Doppler used to avoid blood vessels) or real-time DSA guidance to puncture to the main trunk of the facial nerve at the stylomastoid foramen; (3) Individualized electrophysiological localization-for patients with mild to moderate functional impairment, low-current (0.3-0.8 mA) nerve trunk functional localization was performed, while for those with severe facial paralysis, anatomical localization was prioritized and verified by electrical stimulation. In terms of treatment, pulsed radiofrequency (42 ℃, 120-180 seconds) modulation or continuous radiofrequency (50-70 ℃) moderate ablation was selected, with abnormal muscle response monitoring (amplitude reduction >50%) and facial symmetry used to determine the therapeutic endpoint. In May 2026, this technique was applied to 6 consecutive patients (5 females, 53-72 years old; 2 cases of hemifacial spasm, 3 cases of Bell's palsy, and 1 case of Hunt syndrome, 6 cases in total). Results: All 6 patients underwent the surgery successfully with no complications. Improvement in House-Brackmann (H-B) grading was observed: 3 cases progressed from Ⅲ to Ⅱ, 1 case from Ⅳ to Ⅱ, and 1 case from Ⅴ to Ⅳ. The median Sunnybrook score increased from 46 to 64.5, with 1 case showing marked improvement and 5 cases showing effectiveness. In HFS patients, the amplitude of abnormal muscle response decreased progressively, and postoperative spasms were immediately relieved. No postoperative persistent worsening of facial paralysis, hematoma, infection, or hearing impairment occurred; only 2 patients experienced temporary mild facial weakness, which improved by discharge. The duration of a single procedure ranged from 20 to 35 minutes. Conclusion: The “triple guidance” percutaneous stylomastoid foramen facial nerve radiofrequency modulation technique achieves dual localization of imaging anatomy and electrophysiological function. It is standardized, reproducible, minimally invasive, and safe, providing a minimally invasive alternative for refractory HFS and filling the gap in neuromodulation treatment for post-facial paralysis sequelae. Its long-term efficacy still requires verification through large-sample and long-term follow-up studies.